Aspen Aerogels price target lowered to $31 from $36 at Roth MKM

Roth MKM lowered the firm’s price target on Aspen Aerogels (ASPN) to $31 from $36 and keeps a Buy rating on the shares after its Q3 results. The firm is positive on the company’s current positioning, including a clear focus on profitable growth as its management positions the portfolio for a strong secular opportunity, the analyst tells investors in a research note. Roth adds that it anticipates some near-term overhang until DOE loan closure, but also looks for outperformance as profitability continues to ramp.